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Abstract
Background: Frataxin is discussed as involved in the biogenesis of iron-sulfur clusters. Recently it
was discovered that a frataxin homologue is a structural component of the respiratory
NADH:ubiquinone oxidoreductase (complex I) in Thermus thermophilus. It was not clear whether
frataxin is in general a component of complex I from bacteria. The Escherichia coli homologue of
frataxin is coined CyaY.
Results: We report that complex I is completely assembled to a stable and active enzyme complex
equipped with all known iron-sulfur clusters in a cyaY mutant of E. coli. However, the amount of
complex I is reduced by one third compared to the parental strain. Western blot analysis and live
cell imaging of CyaY engineered with a GFP demonstrated that CyaY is located in the cytoplasm
and not attached to the membrane as to be expected if it were a component of complex I.
Conclusion: CyaY plays a non-essential role in the assembly of complex I in E. coli. It is not a
structural component but may transiently interact with the complex.
Background
The NADH:ubiquinone oxidoreductase, also known as
respiratory complex I, is the entry point for electrons in
the respiratory chains of most bacteria and many eucary-
otes. It links the electron transfer from NADH to ubiqui-
none with the translocation of protons across the
membrane. In doing so, complex I establishes a proton
motive force required for energy consuming processes [1-
5]. One FMN and, depending on the species, eight to nine
iron-sulfur (Fe/S) clusters participate in the electron trans-
fer reaction. Generally, the bacterial complex I consists of
14 different subunits called NuoA through NuoN (or
Nqo1 through Nqo14; [5-10]). In a few bacteria such as
Escherichia coli and Aquifex aeolicus the genes nuoC and
nuoD are fused resulting in a complex consisting of 13
subunits. Seven (or six, see above) peripheral proteins
including those that bear all known redox groups build up
the so-called peripheral arm of the complex, which
extends into the aqueous medium. The residual seven
subunits are hydrophobic proteins and build the mem-
brane arm of the complex. The arrangement of both arms
of the complex have been visualized by means of electron
microscopy [11,12].
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Recently, the structure of the peripheral arm of the com-
plex from Thermus thermophilus was resolved at 3.3 Å reso-
lution [13]. This pathbreaking study revealed the
unexpected presence of a 15th subunit in the T. ther-
mophilus complex [13,14]. The subunit was coined Nqo15
and exhibits structural similarity to the frataxin family.
Nqo15 shows a 2.5 Å RMSD to the structure of CyaY, the
E. coli frataxin homologue [13,15]. Despite the similar
three-dimensional fold, the sequence similarity of Nqo15
to members of the frataxin family is very low. Homo-
logues of Nqo15 were only detected in close relatives of
Thermus, such as Deinococcus species [13,14].
Frataxin was first recognized in patients suffering from
Friedreich's ataxia [16-18]. Its loss in patients results in a
neurodegenerative disease due to an unbalanced iron
homeostasis and oxidative damage [16-19]. The exact
physiological function of frataxin is still under debate.
Frataxin has been shown to specifically albeit weakly bind
iron [20] and it was discussed that it is involved in the
assembly of Fe/S clusters [21-23]. Recently, it was shown
in E. coli that CyaY binds to IscS, the cysteine desulfurase
of the ISC-system, and delivers iron to the scaffold protein
IscU [24]. The deletion of cyaY in E. coli had no effect on
the cellular iron content and its sensitivity to oxidants [25]
but it was shown in Salmonella enterica that the deletion of
cyaY in combination with other specific lesions resulted in
severe metabolic defects [26].
In this study, we used a cyaY deletion mutant to investi-
gate whether or not CyaY is a structural component of the
E. coli complex I. Our data show that this is not the case
but that CyaY is most likely a non-essential component
for the assembly of the E. coli complex I.
Results
Enzymatic activity of complex I
E. coli contains two membrane-bound NADH dehydroge-
nases, the energy-converting complex I and a non-energy-
converting, alternative NADH dehydrogenase [9]. While
NADH is a substrate for both enzymes the artificial sub-
strate deamino (d)-NADH is only a poor substrate for the
alternative dehydrogenase and used to descriminate both
enzymes [27,28]. The NADH/ferricyanide oxidoreductase
activity of the cytoplasmic membranes was virtually iden-
tical in the parental strain and the cyaY deletion strain
(Table 1). Thus, the total amount of complex I and the
alternative NADH dehydrogenase did not differ in the
strains.
The physiological NADH oxidase activity of the parental
strain was inhibited by 52% by annonin VI, which selec-
tively blocks complex I (Table 1), as observed with other
E. coli strains [29]. The inhibitor-insensitive activity
derived from the alternative NADH dehydrogenase. The
d-NADH oxidase activity of this strain, which stems from
complex I, was 62% of the activity with NADH as sub-
strate and completely inhibited by annonin VI (Table 1).
Using the cyaY deletion strain, an NADH oxidase activity
similar to the parental strain was measured, but the inhi-
bition of the activity by annonin VI was approximately
20% (Table 1). This indicated a higher amount of the
alternative NADH dehydrogenase in the strain. The d-
NADH oxidase activity of the mutant membranes was
39% of the activity with NADH as substrate and 28%
lower than the rate measured with the membranes from
the parental strain (Table 1). As in the membranes from
the parental strain, the d-NADH oxidase activity was fully
sensitive to annonin VI, indicating that the d-NADH oxi-
dase activity in this strain derived from complex I. The
data demonstrate that a functionally active complex I is
present in the cytoplasmic membranes of the cyaY dele-
tion mutant, but in a lesser amount.
To investigate whether the cyaY deletion had an effect on
other Fe/S cluster containing complexes of the E. coli res-
piratory chain, we measured the succinate oxidase activity
of the cytoplasmic membranes from both strains. This
activity was fully sensitive to malonate (Table 1), a specific
Table 1: Catalytic activities of cytoplasmic membranes from the parental and the cyaY deletion strain. The data are the mean of three 
independent measurements.
Strain NADH/ferricyanide 
oxidoreductase activity
NADH oxidase 
activity
Inhibition by 
annonin VI
d-NADH oxidase 
activity
Inhibition by annonin 
VI
[μmol· min-1 ·mg-1][ μmol· min-1 ·mg-1][ % ][ μmol· min-1· mg-1][ % ]
BW25113 2.6 ± 0.5 0.29 ± 0.03 52 0.18 ± 0.01 100
BW25113 cyaY::nptI 2.7 ± 0.7 0.33 ± 0.06 21 0.13 ± 0.01 100
Strain Succinate oxidase activity Inhibition by malonate
[μmol· min-1 ·mg-1][ % ]
BW25113 0.12 ± 0.01 100
BW25113 cyaY::nptI 0.09 ± 0.01 100BMC Biochemistry 2007, 8:13 http://www.biomedcentral.com/1471-2091/8/13
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inhibitor of the E. coli succinate dehydrogenase, the respi-
ratory complex II. The succinate oxidase activity in the
mutant membranes was 75% of the activity measured in
the membranes of the parental strain (Table 1). Thus, the
cyaY deletion mutant contains an active succinate dehy-
drogenase but in lesser amounts. From these measure-
ments it is concluded that the amount of complex I
containing nine Fe/S cluster is reduced by one third and
the amount of complex II containing three Fe/S clusters by
one quarter in the cyaY deletion strain.
Structural integrity of complex I
The structural integrity of the complex from the parental
and the deletion strain was determined by sucrose gradi-
ent centrifugation (Fig. 1). Proteins of the cytoplasmic
membranes were extracted with 3% (w/v) DDM and cen-
trifuged for 30 min at 150000 × g. The solubilized pro-
teins of the supernatant were separated on a 5–30% (w/v)
sucrose gradient by means of ultra-centrifugation for 18 h
at 160000 × g. Under these conditions complex I sedi-
mented two thirds of the way through the gradient as indi-
cated by its NADH/ferricyanide oxidoreductase activity
([30,31] Fig. 1). NADH/ferricyanide oxidoreductase activ-
ity was detectable in corresponding fractions of the gradi-
ent from the parental and the mutant strains indicating
that complex I was fully assembled (Fig. 1). The total
NADH/ferricyanide oxidoreductase activity of the peak
fractions of the mutant strain was two thirds of that of the
parental strain. Thus, the amount of complex I in the
mutant strain is reduced by approximately one third of
that of the parental strain, which is in good agreement
with the data obtained from the d-NADH oxidase activity
(Table 1).
No enhanced NADH/ferricyanide oxidoreductase activity
was detected in fractions of the gradient corresponding to
higher molecular masses, revealing that the complex from
the cyaY deletion strain showed no tendency to aggregate
(Fig. 1). No NADH/ferricyanide oxidoreductase activity
was detected in fractions 7 to 10 corresponding to the
position of a soluble fragment of the complex [30,32],
indicating that the complex from the deletion strain did
not disintegrate. The NADH/ferricyanide oxidoreductase
activity around fraction 5 is due to the alternative NADH
dehydrogenase [30]. The activity of this fraction was
approximately doubled in the gradient obtained from the
cyaY deletion strain, demonstrating an enhanced amount
of the alternative NADH dehydrogenase in the mutant
strain as already indicated by its NADH oxidase activity
(Table 1). Thus, a stable complex I was properly assem-
bled in the absence of CyaY.
Preparation of complex I
Complex I was isolated from the parental and the mutant
strains using a protocol developed in our laboratory
(Table 2). Proteins were extracted from the cytoplasmic
membranes by DDM and excess detergent was removed
by a fast anion-exchange chromatography on EMD-fracto-
gel. Fractions with NADH/ferricyanide oxidoreductase
activity were pooled and subjected to a second anion-
exchange chromatography on Source 15Q. Peak fractions
were pooled and the complex was purified by means of
size-exclusion chromatography on Sephacryl S-300 HR
(Fig. 2). Complex I eluted from the anion-exchange chro-
matography on Source 15Q at 220 mM NaCl. The final
size-exclusion chromatography on Sephacryl S-300
showed a peak coeluting with the complex I activity at 215
mL (Fig. 2). From both strains 2–3 mg complex I were
obtained. Complex I isolated from the parental and the
deletion strain was reactivated by addition of phospholi-
pids as described [33]. Both preparations catalyzed elec-
tron transfer from NADH to ubiquinone with a rate of 3.0
± 0.3 μmol NADH min-1mg-1 in the presence of 100 μM
NADH and 50 μM decyl-ubiquinone. This is similar to the
rate obtained with the complex from other E. coli strains
[29].
Sucrose gradient centrifugation of detergent extracts of cyto- plasmic membranes Figure 1
Sucrose gradient centrifugation of detergent 
extracts of cytoplasmic membranes. Cytoplasmic mem-
branes of strains BW25113 (●) and BW25113 cyaY::nptI (■) 
were isolated. Proteins were extracted from cytoplasmic 
membranes with 3% dodecyl maltoside (w/v) and separated 
by means of gradients of 5–30% sucrose in 50 mM MES/
NaOH, 50 mM NaCl, 5 mM MgCl2 and 0.1% dodecyl malto-
side, pH 6.0. The gradient with the extract from the parental 
strain was loaded with 32 mg protein and the gradient with 
the extract from the mutant membranes with 37 mg protein. 
The activities shown were calculated to the same amount of 
37 mg protein to allow a direct comparison. Fractions of the 
gradients (numbered 1–20 from top to bottom) were col-
lected and analyzed for NADH/ferricyanide oxidoreductase 
activity.BMC Biochemistry 2007, 8:13 http://www.biomedcentral.com/1471-2091/8/13
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SDS-PAGE of the preparations from the parental strain
and the cyaY deletion mutant indicated the presence of all
complex I subunits (Fig. 3). The subunits NuoE and J were
not separated by SDS-PAGE as reported previously
[31,34]. The preparation from the deletion strain con-
tained a minor impurity with an apparent molecular mass
of about 50 kDa (Fig. 3). An additional subunit with an
apparent molecular mass of 12 kDa, the molecular mass
of CyaY, was not detectable in the preparation of the com-
plex from the parental strain (Fig. 3).
The CyaY protein decorated with a His-tag was overpro-
duced and purified by affinity chromatography by means
of His Spin-Trap on Ni-Sepharose. SDS-PAGE showed the
presence of two proteins in the preparation with apparent
molecular masses of 12 and 25 kDa, respectively. The
molecular mass of CyaY as deduced from its DNA
sequence is 12.2 kDa [35]. Thus, the two proteins were
attributed to the monomeric and the dimeric form of
CyaY, due to a different load with iron [36]. The electro-
phoretic mobility of the monomeric form of CyaY did not
match the mobility of any of the complex I subunits of the
preparation from the parental strain (Fig. 3). The CyaY
homologue of T. thermophilus, Nqo15, was detected in its
monomeric form after SDS-PAGE of the peripheral arm of
the complex [14]. Thus, none of the obtained data indi-
cated that CyaY could be an integral component of the E.
coli complex I.
EPR spectroscopic characterization of complex I
The complex I preparations from the parental and the
mutant strain were concentrated to 3 mg/mL and reduced
by addition of a 1000-fold molar excess of NADH in the
presence of dithionite. EPR spectra recorded at 40 K
revealed the contributions of the binuclear Fe/S clusters
N1a and N1b, spectra recorded at 13 K contained in addi-
tion the signals from the tetranuclear Fe/S clusters N2, N3,
and N4 [3,37]. The signals of the Fe/S clusters N1a were
detected at gx,y,z = 1.92, 1.94, and 2.00 and thoses of N1b
at g//,⊥ = 2.03 and 1.94 ([38]; Fig. 4). The signal of N1a at
g = 2.00 overlaps with a small radical signal due to the
reduction by dithionite. Differences concerning the g-val-
ues and the amplitudes of the signals were not detectable.
Table 2: Preparation of complex I. Isolation of E. coli complex I from strain BW25113 cyaY::nptI starting from 76 g cells (wet weight)*.
Preparation Volume [mL] Protein [mg] NADH/ferricyanide oxidoreductase activity Yield [%]
total [μmol· min-1] specific [μmol· min-1 ·mg-1]
Membranes 280 9100 43530 4.8 100
Extract 64 2010 14680 7.3 34
Fractogel EMD 104 395 3490 9 8
Source 15Q 32 90 1000 11 2
Sephacryl S-300 12 3 137 41 0.3
*Similar values were obtained for the preparation of the complex from the parental strain.
Complex I preparation Figure 2
Complex I preparation. Isolation of E. coli complex I from 
strain BW25113 cyaY::nptI. Chromatography on Fractogel 
EMD TMAE Hicap M (a); chromatography on Source 15Q 
(b); chromatography on Sephacryl S-300 HR (c); absorbance 
at 280 nm (-); NADH/ferricyanide oxidoreductase activity 
(▪); NaCl gradient (--).BMC Biochemistry 2007, 8:13 http://www.biomedcentral.com/1471-2091/8/13
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The signals of the clusters N2 at g//,⊥ = 1.91 and 2.05, N3
at gx,y,z = 1.88, 1.92, and 2.04, and N4 at gx,y,z = 1.89, 1.93,
and 2.09 were present in the spectra of the preparations
from the parental strain as well as from the mutant strain
([30,31]; Fig. 4). Thus, differences concerning the Fe/S
cluster content and composition were not detectable
between the preparations of complex I from the parental
and the cyaY deletion strain.
Localization of CyaY by western blot analysis
In order to determine the localization of CyaY, the cyaY
deletion strain was complemented with pCA24NcyaY
coding for the His-tagged CyaY. After induction with
IPTG, cells were grown to the late exponential phase, col-
lected by centrifugation and washed twice with 50 mM
MES/NaOH pH 6.0. The cells were broken by a single pass
through a french pressure cell, the cell debris was removed
by centrifugation and the cytoplasmic and the membrane
fraction separated by ultra-centrifugation at 250000 × g
for 1 h. The membranes were resuspended and washed
three times in 50 mM MES/NaOH, 50 mM NaCl, pH 6.0.
Proteins of the cytoplasmic and the membrane fraction
were separated by SDS-PAGE and blotted onto a nitrocel-
lulose membrane. The His-tagged CyaY was detected by
an antibody directed against the His-tag (Fig. 5). A clear
signal corresponding to a protein of a molecular mass of
12 kDa was detected in the cytoplasmic fraction but not in
the membrane fraction (Fig. 5). Thus, at least the vast
majority of CyaY is located in the cytoplasmic fraction and
not associated with the membrane.
The overproduced CyaY modified with a His-tag was capa-
ble of binding 6.7 ± 0.5 mol Fe3+/mol CyaY under aerobic
conditions. It has been shown that recombinant CyaY can
bind eight Fe3+ [20]. Thus, failure to detect CyaY within
the membrane fraction is not due to a distorted Fe-bind-
ing of the recombinant protein.
Life cell imaging of CyaY
If CyaY was a structural component of the E. coli complex
I it should be preferentially located close to the mem-
brane. In another approach to determine the cellular loca-
tion of CyaY, a GFP-fusion of the protein was
EPR spectroscopic characterization of complex I Figure 4
EPR spectroscopic characterization of complex I. EPR 
spectra of complex I isolated from the parental (a) and the 
deletion strain (b). The spectra shown in (A) were recorded 
at 40 K and 2 mW microwave power, the spectra shown in 
(B) were recorded at 13 K and 5 mW microwave power. 
The signals of the Fe/S clusters N1a, N1b, N2, N3 and N4 
are indicated. The signal of cluster N1a is nearly saturated at 
13 K and 5 mW. Other EPR conditions were: microwave fre-
quency, 9.44 GHz; modulation amplitude, 0.6 mT; time con-
stant, 0.124 s; scan rate, 17.9 mT/min.
SDS PAGE analysis Figure 3
SDS PAGE analysis. SDS PAGE of the complex I prepara-
tions from the strain BW25113 (a) and BW25113 cyaY::nptI 
(c) and the overproduced and isolated His-tagged CyaY (b). 
The assignment of the individual bands to the corresponding 
complex I subunits is given. The band below NuoG repre-
sents a degradation product of NuoG. The lane with the 
preparation from the parental strain was loaded with 100 μg 
protein, the lane with the preparation from the deletion 
strain with 80 μg protein. The gel was stained with coomas-
sie R250.BMC Biochemistry 2007, 8:13 http://www.biomedcentral.com/1471-2091/8/13
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overproduced in the cyaY deletion strain. As a control, a
NuoJ-GFP fusion was expressed from a plasmid, which
resulted in a clear fluorescent stain of the E. coli inner
membrane, but not of the cytosol (Fig. 6A). The cyaY-gfp
construct was expressed under the control of the araBAD-
promotor of pBAD. After induction with arabinose the
cells showed green fluorescence (Fig. 6B), which was
greatly diminished by repressing the expression with glu-
cose (data not shown). The GFP fluorescence was regu-
larly distributed throughout the cytoplasm. No clustering
of the fluorescence close to the membrane comparable to
that of NuoJ-GFP was observed. The membrane was
stained with the vital dye FM4-64 (Fig. 6). Thus, CyaY is in
vivo not attached to the cytoplasmic membrane and there-
fore not a structural component of complex I.
Discussion
The previously unrecognized protein Nqo15 was found to
be a structural component of the T. thermophilus complex
I [13,14]. This soluble protein was co-purified with the
preparation of the peripheral arm of the respiratory com-
plex I from the membrane fraction of the disrupted cells.
It co-eluted with the peripheral arm from four different
chromatographic steps, and SDS-PAGE of the preparation
revealed that it was present in stoichiometric amounts
[14]. Finally, the crystal structure of the peripheral arm
unambiguously showed that this subunit is an integral
part of the T. thermophilus complex I [13].
The genes comprising the structural subunits of the bacte-
rial complex I are for the most part organized in one
operon or in one or more gene clusters [6,7]. The complex
I gene clusters in Rhodobacter capsulatus [39] and Paracoc-
cus denitrificans [9] contain additional ORFs that are not
related to each other. These ORFs do not encode known
complex I subunits and it has been shown that a disrup-
tion of the ORFs has no influence on the assembly and the
enzymatic activity of complex I [5,39]. The gene coding
the CyaY homologue in T. thermophilus is neither located
within nor in close proximity to the complex I gene clus-
ter. Thus, the finding of this protein as an integral com-
plex I component was completely unexpected [14].
The assignment of Nqo15 to the family of frataxin single
domain proteins (cd00503) was not obvious from its pri-
mary structure. Solely the crystal structure revealed that
Nqo15 exhibits the typical fold of a member of the
frataxin family [13]. Electron density for bound iron was
not detected in the structure, implying that the metal
might have been lost during purification. Here, we have
shown that the frataxin homologue of E. coli CyaY is not
a structural component of complex I. The preparation of
complex I from the wild type did not contain a subunit of
an apparent molecular mass corresponding to the molec-
ular mass of CyaY (Fig. 3). The complex I was fully assem-
bled in the membrane of the mutant and contains all
subunits and known cofactors (Table 1; Figs. 1, 3, and 4).
Its physiological NADH:decyl-ubiquinone oxidoreduct-
ase activity was indistinguishable from the activity of the
complex I preparation from wild type. We were able to
verify the analyses in vivo, because GFP-labelled CyaY did
not associate with the membrane like NuoJ, but showed a
cytosolic localization. Thus, it is reasonable to assume
that CyaY is not a structural component of the E. coli com-
plex I.
Life cell imaging Figure 6
Life cell imaging. Fluorescence microscopy of growing E. 
coli cells. A) Nomarski DIC (bright field) image and GFP chan-
nel of cells expressing NuoJ-GFP, B) FM4-64 stained mem-
branes or GFP fluorescence of cells expressing CyaY-GFP. 
White bars 2 μm.
Localization of CyaY by western blot analysis Figure 5
Localization of CyaY by western blot analysis. West-
ern blot of the membrane (A) and cytoplasmic (B) fraction of 
strain BW25113 cyaY::nptI/pCA24NcyaY. The gel was loaded 
with 150 μg of membrane proteins and 40 μg of cytoplasmic 
proteins. Western blotting was performed with an anti-
penta-His antibody.BMC Biochemistry 2007, 8:13 http://www.biomedcentral.com/1471-2091/8/13
Page 7 of 10
(page number not for citation purposes)
An important finding in this study is that the amount of
complex I in the mutant was reduced by one third as
derived from the inhibitor-sensitive portion of the NADH
oxidase activity and the d-NADH oxidase activity of the
membranes (Table 1) as well as from the sucrose gradient
centrifugation of detergent extracts (Fig. 1). The overall
NADH dehydrogenase activity of the membranes did not
change as indicated by the unaltered NADH/ferricyanide
oxidoreductase activity (Table 1). These data demonstrate
that the amount of the alternative NADH dehydrogenase
is increased approximately two-fold. Thus, the ratio of
complex I to the alternative enzyme changed due to the
deletion of cyaY. This might be due to a change of the met-
abolic and/or redox state of the mutant cells. However, it
is well known that mutations in the complex I genes lead-
ing to a decreased amount of the complex or the assembly
of an inactive complex result in a two-fold enhanced pro-
duction of the alternative enzyme [10,27,29,30]. There-
fore, it seems rather unlikely that the deletion of cyaY
changed the properties of the cell leading to a subsequent
change of the ratio of complex I to the alternative NADH
dehydrogenase.
The deletion of cyaY led to a decrease of the complex I and
complex II content of the cytoplasmic membrane by
approximately one third and one quarter, respectively
(Table 1). This implies a transient interaction between
CyaY and the complexes of the E. coli respiratory chain. It
is possible that CyaY is involved in either biogenesis or
repair of the Fe/S clusters of the complexes containing Fe/
S clusters. The stoichiometry of the individual Fe/S clus-
ters in complex I were not distinguishable in the prepara-
tion from wild type and the cyaY deletion strain (Fig. 4). If
CyaY played a role in the repair of Fe/S clusters this would
imply that complex I with damaged Fe/S clusters has to be
degraded in the mutant membranes.
It was proposed that CyaY is not involved in the biogen-
esis of Fe/S clusters but may serve as an iron chaperone
binding cellular iron in order to reduce oxidative damage
under oxidative stress [40]. According to this CyaY binds
redox active iron and prevents the formation of hydrogen
peroxide [40]. A deletion of CyaY leads to an increased
cellular amount of reactive oxygen species which subse-
quently destroys Fe/S clusters in iron-sulfur proteins [40].
If the oxidative damage of the Fe/S clusters due to the dele-
tion of CyaY leads to the reduced content of complex I all
clusters of the complex would be concerned to the same
extent, as the stoichiometry of the individual Fe/S clusters
is virtually identical in the preparation from wild type and
the cyaY deletion strain (Fig. 4). This is rather unlikely
because the accessibility of the Fe/S clusters of complex I
and the polarity of their environment differ significantly
[13]. If CyaY played a role in preventing a damage of the
Fe/S clusters this would again imply that complex I with
damaged Fe/S clusters has to be degraded in the mutant
membranes. However, it has been demonstrated that
complex I with a reduced content of a single Fe/S cluster is
stable in the membrane [29,38].
Thus, it is more likely that CyaY is one component of the
machinery of Fe/S cluster biogenesis as proposed
[24,41,42]. Formation of Fe/S clusters require complex
biosynthesis systems which share the involvement of
cysteine desulfurases and Fe/S cluster scaffold proteins
[42,43]. The desulfurase catalyzes the reductive conver-
sion of cysteine to alanine and sulfide. Together with iron,
the sulfide is assembled to a binuclear Fe/S cluster on the
scaffold protein. The dimer of the scaffold protein is able
to build a tetranuclear Fe/S cluster out of the two binu-
clear clusters [44]. Due to the low solubility of iron and its
toxicity in the cell, the presence of an iron donor protein
is most likely. The role of the protein would be to bind
and hence solubilize the iron, and to transport and deliver
it to the desulfurase/scaffold proteins. In this respect it
should not be essential for the biosynthetic reaction.
There is evidence that frataxin is the protein sought after.
It was shown that frataxins are able to bind iron and exist
in oligomeric forms, which seem to be the active species
[20,24,44-47] and that they interact with the scaffold pro-
tein and the desulfurase [23,24]. In agreement with the
proposed function of the iron donor protein, it was
shown that the deletion of the corresponding genes in
yeast and in E. coli is not lethal [21,25]. In accordance
with these data, the deletion of cyaY leads to a reduced
content of complex I and II in E. coli, most likely due to a
reduced biogenesis of their Fe/S clusters, but it did not sig-
nificantly change the growth rate of the mutant strain.
Conclusion
The E. coli frataxin homologue CyaY is located in the cyto-
plasm and is therefore not a structural component of com-
plex I. A cyaY deletion mutant showed a reduced complex
I and complex II production which may be a result of the
disturbance of the Fe/S cluster assembly machinery. Fur-
ther studies are necessary to determine if a transient inter-
action between the complexes of the respiratory chain and
CyaY takes place during the biogenesis of the Fe/S clusters.
Methods
Strains, plasmids and gene expression
E. coli K-12 strains AG1, BW25113 and BW25113
cyaY::nptI were kindly provided by the Keio collection of
the Nara Institute of Science and Technology (National
BioResource Project (NIG, Japan): E. coli) [48]. The plas-
mids pCA24NcyaY  and pCA24NcyaY-gfp were obtained
from the ASKA library [49]. They contain the sequence
coding for CyaY with an N-terminal 6× histidine (His)-tag
(pCA24NcyaY) and an additional C-terminal GFP-fusion
(pCA24NcyaY-gfp). The plasmid pGFPe nuoJ contains nuoJBMC Biochemistry 2007, 8:13 http://www.biomedcentral.com/1471-2091/8/13
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engineered with a C-terminal GFP-fusion and was kindly
provided by Drs. Gunnar von Heijne and Daniel Daley
[50]. The expression host BL21(DE3) for pGFPe nuoJ was
purchased from Novagen. Strains were grown in LB
medium at 37°C until early stationary phase. Cells used
for fluorescence microscopy were grown in M9 minimal
medium with 30 mM mannitol as carbon source at 25°C.
Chloramphenicol (100 μg/mL) and kanamycin (50 μg/
ml) were supplemented when necessary. Expression of
pBADcyaY-gfp (see below) was induced by adding 0.2%
(w/v) L-arabinose to the media and repressed in the pres-
ence of 0.2% (w/v) D-glucose. Expression of pCA24NcyaY
and pGFPe nuoJ was induced by an addition of 1 mM iso-
propyl-β-D-thiogalactopyranoside.
Cloning of pBADcyaY-gfp
The  cyaY-gfp  fusion was PCR-amplified from
pCA24NcyaY-gfp  using Phusion DNA Polymerase
(Finnzymes) and primers XbaI-cyaY (5'AGTTCTAGAAGG
AGGAATTCACCATGAACACAGTGAATTTCATCGCCTG)
and  gfp-HindIII  (5'-AGTAAGCTTGCAGGTCGACCCT-
TAGCG) and cloned in pBAD33 [51] using the same
primers. The forward primer contains a synthetic ribos-
omal binding site AGGAGG 8 nt upstream of the initia-
tion codon. The PCR product was cut with XbaI  and
HindIII and ligated to XbaI-HindIII sites of pBAD33 down-
stream of the araBAD promotor.
Protein purification
Complex I was isolated similarly to the procedure
described [33]. All steps were carried out at 4°C. 76 g cells
were resuspended in a 5-fold volume of 50 mM MES/
NaOH, 0.1 mM phenylmethanesulfonyl fluoride, pH 6.0,
with 10 μg/mL DNAseI and 50 μg/mL lysozyme and dis-
rupted by a single pass through a French Pressure cell
(SLM Aminco) at 110 MPa. Cell debris was removed by
centrifugation at 36000 × g for 20 min and cytoplasmic
membranes were obtained by centrifugation at 250000 ×
g for 1 h. The membranes were resuspended in 50 mM
MES/NaOH, 50 mM NaCl, pH 6.0 at a protein concentra-
tion of 80 mg/mL. n-Dodecyl-β-D-maltopyranoside
(DDM, AppliChem) was added to a final concentration of
3% and the solution was gently homogenized and centri-
fuged for 20 min at 250000 × g. The supernatant was
applied to a 120 mL Fractogel EMD TMAE Hicap M
(Merck) column equilibrated in 50 mM MES/NaOH, 50
mM NaCl and 0.1% DDM, pH 6.0. The column was
eluted with a 150 mL linear gradient of 150–350 mM
NaCl in 50 mM MES/NaOH, 0.1% DDM, pH 6.0 at a flow
rate of 15 mL/min. Fractions containing NADH/ferricya-
nide oxidoreductase activity were combined, concentrated
by precipitation with 9% (w/v; final concentration)
poly(ethylene glycol) 4000 and dissolved in 5 mL 50 mM
MES/NaOH, 50 mM NaCl and 0.1% DDM, pH 6.0. The
proteins were loaded onto a 80 mL Source 15Q (GE
Healthcare) column equilibrated in 50 mM MES/NaOH,
50 mM NaCl and 0.1% DDM, pH 6.0. The column was
eluted with a 500 mL linear gradient of 125–275 mM
NaCl in 50 mM MES/NaOH, 0.1% DDM, pH 6.0 at a flow
rate of 5 mL/min. Fractions containing NADH/ferricya-
nide oxidoreductase activity were pooled and concen-
trated with a 100 kDa MWCO Amicon Ultra-15
centrifugal filter (Millipore). The concentrated protein
solution was subjected to size-exclusion chromatography
on a 450 mL Sephacryl S-300 HR (GE Healthcare) column
in 50 mM MES/NaOH, 50 mM NaCl, and 0.1% DDM, pH
6.0, at a flow rate of 20 mL/h. Peak fractions of NADH/fer-
ricyanide oxidoreductase activity were combined and
stored at -80°C.
His-tagged CyaY was isolated from strain AG1/
pCA24NcyaY. For SDS-PAGE analysis 0.24 g wet cells were
treated with Bugbuster protein extraction reagent (Nova-
gen) according to manufacturer's recommendations. Cell
debris and lipids were removed by centrifugation at
150000 × g for 15 min at 4°C and the supernatant was
adjusted to 20 mM imidazole and loaded onto a 100 μL
His Spin-Trap column (GE Healthcare). After washing
with 600 μL 20 mM imidazole in 20 mM Na3PO4/HCl pH
7.4 and 600 μL 500 mM imidazole in 20 mM Na3PO4/
HCl pH 7.4 the protein was eluted with 600 μL 1 M imi-
dazole in 20 mM Na3PO4/HCl pH 7.4.
For determination of iron binding capacity His-tagged
CyaY was isolated from 2 g wet cells. All steps were carried
out at 4°C. The cells were resuspended in a 10-fold vol-
ume of 20 mM Na3PO4/HCl, 20 mM imidazole, 500 mM
NaCl 0.1 mM phenylmethanesulfonyl fluoride, pH 7.4
(binding buffer), with 10 μg/mL DNAseI and 50 μg/mL
lysozyme and disrupted by a single pass through a French
Pressure cell (SLM Aminco) at 110 MPa. Cell debris and
membranes were removed by centrifugation at 250000 ×
g for 1 h. The supernatant was loaded onto a 15 mL
ProBond Ni2+-IDA column equilibrated in binding buffer.
The column was washed with 80 mL of binding buffer and
proteins were eluted with a 60 mL linear gradient of 20–
1000 mM imidazole in binding buffer. Fractions were
analyzed by SDS-PAGE and those containing His-tagged
CyaY were combined and concentrated by a 3 kDa
MWCO Vivaspin 20 centrifugal filter (Vivascience).
EPR spectroscopy
EPR spectroscopy was performed with a Bruker EMX 1/6
spectrometer operating at X-band (9.2 GHz) according to
[30]. The magnetic field was calibrated using a strong or a
weak pitch standard. The isolated complex I (3 mg/mL)
was reduced with a few grains of dithionite in the presence
of a 1000-fold molar excess of NADH.BMC Biochemistry 2007, 8:13 http://www.biomedcentral.com/1471-2091/8/13
Page 9 of 10
(page number not for citation purposes)
Enzyme activity
Complex I activity in the cytoplasmic membranes was
measured either as NADH/ferricyanide oxidoreductase
activity or as d-NADH oxidase activity as described
[27,29]. The d-NADH oxidase activity was inhibited by
addition of 20 μM annonin VI, a specific complex I inhib-
itor [27]. The NADH:decyl-ubiquinone oxidoreductase
activity of isolated complex I was determined as described
[31]. The succinate oxidase activity of cytoplasmic mem-
branes was measured with a clark oxygen electrode. To
remove tightly bound oxaloacetate at the active site and to
express the full catalytic activity of succinate dehydroge-
nase, cytoplasmic membranes corresponding to 600 μg
protein were incubated for 10 min in 2 mL 30 mM
Na2HPO4/HCl pH 7.4 at 30°C [52]. The reaction was ini-
tiated by the addition of 20 mM succinate and inhibited
in the presence of 40 mM malonate.
Iron binding to modified CyaY
The binding of iron to the overproduced and His-tagged
CyaY was determined according to [24]. Purified CyaY
was incubated with a 15-fold molar excess of Fe3+ in form
of ferric ammonium citrate under aerobic conditions at
4°C for 1 hour. The mixtures were centrifuged at 16000 ×
g and desalted on a 20 mL Sephadex G25 superfine col-
umn (Amersham Pharmacia) equilibrated in 50 mM Tris/
HCl, 50 mM NaCl, pH 7.0. The iron content of the prepa-
ration before and after loading with Fe3+ was determined
according to [53].
Fluorescence microscopy
Cells at mid-exponential phase were placed on a micro-
scope slide covered with a pad of 1% (w/v) agarose in M9-
mannitol minimal media. A cover slip was placed on the
cells and images were acquired with a Axio Imager A.1 flu-
orescence microscope (Zeiss) at 1000× magnification. Pic-
tures were acquired with a digital CCD camera and
processed with Metamorph 4.6 (Universal Imagin Corp.,
USA). The cytoplasmic membranes were stained with 1
nM N-(3-triethylammoniumpropyl)-4-(p-diethylami-
nophenylhexatrienyl)pyridinium dibromide (FM4-64).
Other Analytical Procedures
Protein concentration was measured either by the biuret
or the Bradford method [54] using BSA as standard. SDS-
PAGE was performed according to the protocol of Schäg-
ger and von Jagow [55], using a 10% T, 3% C separating
gel. The concentration of the isolated proteins was deter-
mined by the absorbance at 280 nm using an extinction
coefficient of 764 mM-1cm-1 for complex I and 30 mM-
1cm-1 for CyaY derived from their DNA sequence. Sucrose-
gradient centrifugation in the presence of 0.1% DDM was
performed as described [30]. Proteins separated by SDS-
PAGE were electroblotted onto 0.45 μm pore size nitrocel-
lulose membrane (Schleicher und Schüll) for western blot
analysis [56]. An Anti-Penta-His antibody (Qiagen) was
used at a 1:400 dilution for detection. The membrane was
incubated for 1 h at 25°C with the primary antibody.
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